help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 50, No. 1 182-185
doi:10.1210/jcem-50-1-182
Copyright © 1980 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SPENCER, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SPENCER, E. M.

Lack of Response of Serum Somatomedin to Hyperprolactinemia in Humans*

E. MARTIN SPENCER

Cancer Research Institute, Metabolic Research Unit and General ClinicalResearch Center, University of California, San Francisco, California 94143

Address all correspondence and requests for reprints to: Dr. E. Martin Spencer, Children's Hospital, 3700 California Street, San Francisco, California 94118

Because animal experiments have suggested that PRL might regulate the serum somatomedin (SM) concentration, the effect of sustained hyperprolactinemia on the serum SM level was studied in patients with proven pituitary microadenomas. PRL was determined by RIA. SM was measured on the same sample by a human placental membrane radioreceptor assay in which all SMs cross-react. The mean serum SM (±SE) in 16 females with elevated PRL levels from 68–21,000 ng/ml was 0.97 ± 0.08 U/ml. Thiswas not statistically different from that of 29 normal women, (P > 0.2). The mean SM for the 3 male patients with serum PRL levels from 570–5,050 ng/ml was in the lower range for normal males. There was no correlation in either group between the serum SM and PRL levels. These results indicate that PRL is not a major regulator of the serum SM concentration in man (J Clin Endocrinol Metab 50: 182,1980)

* This work was supported by grants from the American Cancer Society (BC-222) and NIH (AM-21301).

Received January 2, 1979.




This article has been cited by other articles:


Home page
ScienceHome page
R. Palmiter, G Norstedt, R. Gelinas, R. Hammer, and R. Brinster
Metallothionein-human GH fusion genes stimulate growth of mice
Science, November 18, 1983; 222(4625): 809 - 814.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society